Search Tag: breast cancer
2025 30 May
Women with extremely dense breast tissue face an elevated risk of breast cancer, alongside decreased mammographic sensitivity. While supplemental magnetic resonance imaging (MRI) has proven effective in detecting cancers in this population, conventional full-protocol MRI examinations are time-consuming and resource-intensive. To address this, researchers...Read more
2025 25 Apr
Neoadjuvant chemotherapy (NAC) is a standard treatment for locally advanced breast cancer, where achieving a pathologic complete response (pCR) is linked to better outcomes and the possibility of breast-conserving surgery. However, 19% to 34.9% of patients do not reach pCR, highlighting the need for tools that can predict treatment response early....Read more
2025 25 Apr
Integration of artificial intelligence into healthcare systems prompts essential questions about efficacy, ethics and patient trust. Among imaging modalities, mammography stands out for its suitability for AI applications due to its standardisation and high volume of diagnostic data. However, clinical implementation hinges not only on technical validation...Read more
2025 25 Apr
Integration of artificial intelligence into healthcare systems prompts essential questions about efficacy, ethics and patient trust. Among imaging modalities, mammography stands out for its suitability for AI applications due to its standardisation and high volume of diagnostic data. However, clinical implementation hinges not only on technical validation...Read more
2025 25 Apr
Integration of artificial intelligence into healthcare systems prompts essential questions about efficacy, ethics and patient trust. Among imaging modalities, mammography stands out for its suitability for AI applications due to its standardisation and high volume of diagnostic data. However, clinical implementation hinges not only on technical validation...Read more
2025 08 Jan
Cardiovascular disease (CVD) and cancer remain leading causes of death. New research from The University of Texas MD Anderson Cancer Center reveals that patients with late-stage or metastatic breast cancer are significantly more likely to have had pre-existing CVD compared to those diagnosed with early-stage breast cancer. Published in...Read more
2024 10 Nov
Breast cancer remains a significant threat, particularly among high-risk women who benefit from supplemental screening methods such as magnetic resonance imaging (MRI). However, even with advanced imaging, certain malignancies are not detected until they have progressed. Recent advancements in artificial intelligence (AI) offer new possibilities...Read more
2024 07 Oct
Axillary lymph node status is crucial in diagnosing and treating early breast cancer. Detecting the presence of lymph node metastases plays an essential role in determining outcomes. Axillary ultrasound (US) is commonly used to assess nodal involvement in clinically node-negative (cN0) patients, especially those treated with breast-conserving therapy....Read more
2024 07 Oct
Axillary lymph node status is crucial in diagnosing and treating early breast cancer. Detecting the presence of lymph node metastases plays an essential role in determining outcomes. Axillary ultrasound (US) is commonly used to assess nodal involvement in clinically node-negative (cN0) patients, especially those treated with breast-conserving therapy....Read more
2024 23 Sep
Breast cancer remains the most commonly diagnosed cancer among women worldwide, and its early detection is critical for improving treatment outcomes and reducing mortality. Traditional mammography, while effective, is limited by its two-dimensional (2D) nature, often leading to false positives, false negatives, and a high recall rate due to overlapping...Read more
2024 15 Sep
Breast cancer remains the most frequently diagnosed cancer among women worldwide. While mammography has been the cornerstone of breast cancer screening, its one-size-fits-all approach has notable limitations, particularly in women with dense breast tissue and those at higher risk. In recent years, the focus has shifted toward more personalised...Read more
2024 15 Sep
Breast cancer remains the most frequently diagnosed cancer among women worldwide. While mammography has been the cornerstone of breast cancer screening, its one-size-fits-all approach has notable limitations, particularly in women with dense breast tissue and those at higher risk. In recent years, the focus has shifted toward more personalised...Read more
2024 09 Sep
Breast cancer is one of the most prevalent cancers among women worldwide and a leading cause of cancer-related deaths. Among the key factors influencing the prognosis and treatment planning for patients with locally advanced breast cancer (LABC) is the presence of axillary lymph node metastases (ALNMs). Accurate detection of ALNMs is crucial as...Read more
2024 30 Jul
Neoadjuvant chemotherapy (NAC) has significantly transformed the landscape of breast cancer (BC) treatment, offering a pivotal approach to reducing tumour size before surgery. Initially, NAC was predominantly utilised for locally advanced or inflammatory BC cases that were inoperable, with the primary aim of enabling less extensive surgical interventions...Read more
2024 30 Jul
Neoadjuvant chemotherapy (NAC) has significantly transformed the landscape of breast cancer (BC) treatment, offering a pivotal approach to reducing tumour size before surgery. Initially, NAC was predominantly utilised for locally advanced or inflammatory BC cases that were inoperable, with the primary aim of enabling less extensive surgical interventions...Read more
2024 10 Jul
Breast cancer is the most prevalent cancer and the leading cause of cancer-related deaths among women. Incidental breast lesions, found in 0.3% to 7.63% of cases during computed tomography (CT) scans, pose a clinical challenge as 31.0% to 70.0% of these lesions are malignant. Dual-energy CT (DECT) captures data at two energy levels, offering enhanced...Read more
2024 10 Jul
Breast cancer is the most prevalent cancer and the leading cause of cancer-related deaths among women. Incidental breast lesions, found in 0.3% to 7.63% of cases during computed tomography (CT) scans, pose a clinical challenge as 31.0% to 70.0% of these lesions are malignant. Dual-energy CT (DECT) captures data at two energy levels, offering enhanced...Read more
2024 18 Jun
Breast cancer is the most common cancer in women, with significant global incidence and mortality rates. The TNM classification system is crucial for accurately determining the extent and progression of the disease, guiding treatment decisions and improving patient outcomes. Currently, ultrasound is the primary method for assessing axillary lymph...Read more
2024 18 Jun
Breast cancer is the most common cancer in women, with significant global incidence and mortality rates. The TNM classification system is crucial for accurately determining the extent and progression of the disease, guiding treatment decisions and improving patient outcomes. Currently, ultrasound is the primary method for assessing axillary lymph...Read more
2024 12 Jun
Screening mammography guidelines recommend that scans be reviewed by multiple physicians. While mammography has significantly improved breast cancer outcomes, screening programmes add a substantial workload to healthcare workers who are already facing shortages. There is considerable interest in using artificial intelligence (AI) to address this...Read more
2024 12 Jun
Screening mammography guidelines recommend that scans be reviewed by multiple physicians. While mammography has significantly improved breast cancer outcomes, screening programmes add a substantial workload to healthcare workers who are already facing shortages. There is considerable interest in using artificial intelligence (AI) to address this...Read more
2024 12 Jun
Screening mammography guidelines recommend that scans be reviewed by multiple physicians. While mammography has significantly improved breast cancer outcomes, screening programmes add a substantial workload to healthcare workers who are already facing shortages. There is considerable interest in using artificial intelligence (AI) to address this...Read more
2024 29 May
Contrast-enhanced mammography (CEM) is a promising breast imaging method utilising iodinated contrast material and low- and high-energy images to highlight hypervascular lesions. Recent research indicates high diagnostic performance in breast cancer detection, especially when interpreting both types of images together, with sensitivity and specificity...Read more
2024 29 May
Contrast-enhanced mammography (CEM) is a promising breast imaging method utilising iodinated contrast material and low- and high-energy images to highlight hypervascular lesions. Recent research indicates high diagnostic performance in breast cancer detection, especially when interpreting both types of images together, with sensitivity and specificity...Read more
2024 30 Apr
Breast cancer is a significant global health concern, with over 2 million new cases diagnosed annually worldwide and nearly 8 million cases existing within a 5-year span. In Europe, it is the most prevalent cancer among women, comprising 15% of new cases overall and 30% among women specifically. Over half a million new cases are diagnosed annually...Read more